I am interested in applying novel genomic methods to critical clinical questions and building new frameworks to analyze large amounts of sequencing data. I am now exploring cancer-related single-cell sequencing data to better understand the mechanism that underlies tumor heterogeneity and support new diagnostic and therapeutic strategies. |